cyclosporine has been researched along with Minimal Disease, Residual in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertrand, Y; Bleyzac, N; Cuzzubbo, D; Domenech, C; Dubois, V; Garnier, N; Goutagny, MP; Goutelle, S; Grardel, N; Janoly-Duménil, A; Plesa, A; Rénard, C | 1 |
| Gonda, A; Illes, A; Miltenyi, Z; Remenyik, E; Tar, I; Toth, J | 1 |
| Bachanova, V; Brunstein, CG; Burke, MJ; Cao, Q; Sandhu, K; Singleton, TP; Verneris, MR; Wagner, JE; Weisdorf, DJ; Yohe, S | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Oka, S; Tsuji, M; Yamano, T; Yokote, T | 1 |
| Bassan, R; Castellino, C; Del Grosso, F; Ferraris, AM; Gallamini, A; Mattei, D; Mordini, N; Peretti, C; Rambaldi, A; Rapezzi, D; Strola, G | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| Beelen, DW; Elmaagacli, AH; Schaefer, UW | 1 |
| Drobyski, WR; Hessner, MJ; Kabler-Babbitt, C; Keever-Taylor, CA; Klein, JP; Margolis, DA; Vesole, DH | 1 |
| Boruczkowski, D; Jólkowska, J; Ladon, D; Leda, M; Pieczonka, A; Wachowiak, J; Witt, M | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
1 trial(s) available for cyclosporine and Minimal Disease, Residual
| Article | Year |
|---|---|
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Mycophenolic Acid; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Secondary Prevention; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
9 other study(ies) available for cyclosporine and Minimal Disease, Residual
| Article | Year |
|---|---|
Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Risk; Survival Rate; Tissue Donors; Young Adult | 2016 |
Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Female; Humans; Immunomodulation; Immunosuppressive Agents; Neoplasm, Residual; Paraneoplastic Syndromes; Pemphigus; Retroperitoneal Neoplasms; Thalidomide | 2009 |
[Graft-versus-ATLL effect induced by abrupt discontinuation of immunosuppression following allogeneic bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; DNA, Viral; Doxorubicin; Graft vs Leukemia Effect; Human T-lymphotropic virus 1; Humans; Immunosuppression Therapy; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Prednisone; Remission Induction; Vincristine | 2005 |
Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Cell Proliferation; Chromosomes, Human, X; Cord Blood Stem Cell Transplantation; Cyclosporine; Diarrhea; Fatal Outcome; Female; Gastrointestinal Agents; Graft Survival; Graft vs Host Disease; Humans; Ileus; Immunosuppressive Agents; Infliximab; Leukemia-Lymphoma, Adult T-Cell; Neoplasm, Residual; Precursor Cells, B-Lymphoid; Transplantation Chimera; Transplantation Conditioning | 2007 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Disease Management; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukocyte Transfusion; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Remission Induction; Retrospective Studies; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Survival Analysis; Treatment Outcome | 1997 |
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Gastrointestinal Hemorrhage; Graft Enhancement, Immunologic; Graft vs Host Disease; Graft vs Tumor Effect; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocyte Transfusion; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neoplasm, Residual; Nuclear Family; Polymerase Chain Reaction; Salvage Therapy; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelog
Topics: Adolescent; Bone Marrow Transplantation; CD3 Complex; Cyclosporine; Female; Graft vs Leukemia Effect; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Transfusion; Neoplasm, Residual; Recurrence; Transplantation Chimera; Transplantation, Homologous | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |